Clinical Trials Logo

Urinary Calculi clinical trials

View clinical trials related to Urinary Calculi.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05759767 Active, not recruiting - Pediatric Disorder Clinical Trials

The Efficacy and Safety of Medical Expulsive Therapy After Extracorporeal Shock Wave Lithotripsy (ESWL) in Pediatric Urolithiasis

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the clinical efficacy and safety of MET after ESWL in pediatric urolithiasis.

NCT ID: NCT05102279 Active, not recruiting - Dietary Supplements Clinical Trials

Analysis of Urine Composition Saturation and Dietary Intervention in Subjects Without Urinary Calculi

Start date: December 23, 2021
Phase: N/A
Study type: Interventional

Urinary calculi have become a global public health problem, which brings a huge economic burden to society and individuals. The pathogenesis of urinary calculi is not completely clear. Supersaturation of urinary components is a necessary condition for the formation of urinary calculi. The causes of stone formation are closely related to diet, drugs, metabolic disorders, basic diseases, genetic factors, environment and so on. Diet essentially determines the composition of urine, which affects the formation of urinary calculi. The effect of dietary phosphorus intake on stones is not clear. There is a lack of data to support dietary phosphorus as an influencing factor of stone formation. Phosphorus is present in most foods. 24h urine composition analysis is of great value in predicting the occurrence and composition of urinary calculi. However, due to the interaction between urine components, a single urine component can not well predict the occurrence of stones. Therefore, the researchers introduced the relative supersaturation of common stone components in urine to predict the incidence of stones. Therefore, we want to give healthy adults a diet with different phosphorus content for a period of time to clarify the effect of phosphorus in the diet on 24h urine composition level and urine relative supersaturation, so as to further explore the relationship between dietary phosphorus and the incidence of urinary calculi. To provide more clear recommendations for early prevention of urinary calculi, and provide more evidence for clinical decision-making, thereby reducing the incidence rate of urinary calculi.

NCT ID: NCT05081960 Active, not recruiting - Kidney Stone Clinical Trials

Evaluating the Vitamin K2 Status of Calcium-based Stone Formers

Start date: August 1, 2022
Phase:
Study type: Observational

This is an observation, single site-study with one study visit during which all data and samples will be collected. Study participants will be asked to provide blood, urine, and fecal samples so that the investigators may study the differences in the gut microbiota, vitamin K2 levels, and other parameters between participants who form kidney stones and those who do not.

NCT ID: NCT04563039 Active, not recruiting - Urinary Stones Clinical Trials

Acoustic Enhancer Research on Laser Lithotripsy (AEROLITH)

AEROLITH
Start date: May 21, 2021
Phase: N/A
Study type: Interventional

A pivotal study to evaluate the safety and effectiveness of Applaud Acoustic Enhancer when used in conjunction with conventional ureteroscopic laser lithotripsy (URS-LL) in the treatment of subjects with urinary stones.

NCT ID: NCT04490343 Active, not recruiting - Urolithiasis Clinical Trials

Detection of Urinary Stones on ULDCT With Deep-learning Image Reconstruction Algorithm

URO DLIR
Start date: July 21, 2020
Phase: N/A
Study type: Interventional

Urolithiasis has an increasing incidence and prevalence worldwide, and some patients may have multiple recurrences. Because these stone-related episodes may lead to multiple diagnostic examinations requiring ionizing radiation, urolithiasis is a natural target for dose reduction efforts. Abdominopelvic low dose CT, which has the highest sensitivity and specificity among available imaging modalities, is the most appropriate diagnostic exam for this pathology. The main objective of this study is to evaluate the diagnostic performance of ultra-low dose CT using deep learning-based reconstruction in urolithiasis patients.

NCT ID: NCT03811171 Active, not recruiting - Renal Calculi Clinical Trials

Break Wave(TM) Extracorporeal Lithotripter First-in-Human Study

Start date: August 20, 2019
Phase: N/A
Study type: Interventional

This is a prospective, open-label, multi-center, single-arm (non-randomized) study to assess the safety and effectiveness of breaking stones in the upper urinary tract using the SonoMotion Break Wave technology. Up to 30 subjects will be included. The procedure will be performed in a hospital surgical environment as an outpatient (without being admitted) or in a non-surgical environment such as a clinic or office procedure room. The procedure will be performed under varying levels of anesthesia ranging from no anesthesia to general anesthesia (fully asleep). Stones will be limited to ≤ 10 mm for lower pole stones and ≤ 20 mm everywhere else. Safety will be measured by the self-reported occurrences of adverse events, unplanned emergency department or clinic visits, and the need for further intervention. Fragmentation will be measured by self-reported stone passage and a comparison of computed tomography (CT) images before and after the procedure.

NCT ID: NCT03243682 Active, not recruiting - Urologic Diseases Clinical Trials

The Alternating Bidirectional Versus The Standard Approach During Shock Wave Lithotripsy For Renal And Upper Lumbar Ureteric Stones

Start date: September 1, 2016
Phase: N/A
Study type: Interventional

compare the outcomes of SWL for renal and upper lumbar ureteric stones using the alternating bidirectional approach versus the standard approach.

NCT ID: NCT01973088 Active, not recruiting - Urinary Calculi Clinical Trials

Screening and Identification of Human Urate Transporter hURAT1 MicroRNA

Start date: November 2013
Phase: N/A
Study type: Observational

This study intends to use in patients with renal tissue and blood samples, screening and identification of renal tissue hURAT1 regulating the expression of micro-RNA, for further study of uric acid stone formation mechanism and the occurrence of clinical preventive uric acid stones provide new clues and new intervention targets.

NCT ID: NCT00959153 Active, not recruiting - Kidney Stones Clinical Trials

Extracorporeal Shock Wave Lithotriptor Indicated for Fragmenting Urinary Stones in the Kidney

Start date: June 2010
Phase: Phase 3
Study type: Interventional

A total of 20 subjects presenting with urinary stone(s) in the kidney or ureter will be treated with an extracorporeal shockwave lithotripsy device to fragment the stones. Subjects will be followed for 14 days. If at the 14 day follow-up visit the subject continues to present with a stone size 4 mm or greater will have an option of retreatment or other intervention. If the subject consents to be retreated at this time, this subject will be followed up for another 14 days.

NCT ID: NCT00575432 Active, not recruiting - Clinical trials for Kidney Transplantation

Evaluation of Kidney Function by Multi-modal Magnetic Resonance Imaging and Spectroscopy

Start date: November 2004
Phase:
Study type: Observational

Multimodal functional magnetic resonance (MR) methods, including MR diffusion, Blood-Oxygenation Level Dependent (BOLD) imaging and MR spectroscopy may provide complementary information about the functional status of a kidney. The researchers hypothesize that these non-invasive methods correlate with histology as "gold standard" and compete favorably with conventional in part invasive evaluation methods, and thus provide specific and early detection of kidney diseases of various etiologies, drug toxicity, or renal allograft dysfunction.